IRIS UniCatt

Sica, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.589
EU - Europa 9.677
AS - Asia 5.321
SA - Sud America 1.049
OC - Oceania 176
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 12
Totale 26.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.331
DE - Germania 2.459
SG - Singapore 1.881
IT - Italia 1.766
CN - Cina 1.707
SE - Svezia 1.701
BR - Brasile 920
FR - Francia 634
IE - Irlanda 616
UA - Ucraina 532
GB - Regno Unito 521
IN - India 464
ID - Indonesia 406
FI - Finlandia 268
RU - Federazione Russa 264
CA - Canada 194
KR - Corea 181
ES - Italia 164
AU - Australia 154
PL - Polonia 138
NL - Olanda 133
TR - Turchia 128
JP - Giappone 112
HK - Hong Kong 84
AT - Austria 66
BE - Belgio 64
IR - Iran 64
CI - Costa d'Avorio 59
CZ - Repubblica Ceca 51
AR - Argentina 50
RO - Romania 43
MX - Messico 39
VN - Vietnam 34
CH - Svizzera 32
HU - Ungheria 29
BG - Bulgaria 25
EG - Egitto 25
IL - Israele 23
NO - Norvegia 23
PT - Portogallo 23
NZ - Nuova Zelanda 22
IQ - Iraq 21
PK - Pakistan 21
TH - Thailandia 21
LT - Lituania 20
TW - Taiwan 20
CO - Colombia 19
BD - Bangladesh 18
GR - Grecia 18
ZA - Sudafrica 16
AE - Emirati Arabi Uniti 14
CL - Cile 14
MA - Marocco 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
DZ - Algeria 13
EC - Ecuador 13
SK - Slovacchia (Repubblica Slovacca) 13
MY - Malesia 12
PH - Filippine 12
PE - Perù 10
RS - Serbia 10
VE - Venezuela 10
NP - Nepal 9
BA - Bosnia-Erzegovina 8
DK - Danimarca 8
HR - Croazia 8
KE - Kenya 8
LB - Libano 8
PA - Panama 8
AZ - Azerbaigian 6
BZ - Belize 6
EU - Europa 6
GE - Georgia 6
KG - Kirghizistan 6
LK - Sri Lanka 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
BO - Bolivia 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
KZ - Kazakistan 5
MD - Moldavia 5
QA - Qatar 5
TN - Tunisia 5
JM - Giamaica 4
LV - Lettonia 4
MG - Madagascar 4
PY - Paraguay 4
SC - Seychelles 4
UY - Uruguay 4
JO - Giordania 3
LI - Liechtenstein 3
LU - Lussemburgo 3
ME - Montenegro 3
MK - Macedonia 3
SI - Slovenia 3
AL - Albania 2
BH - Bahrain 2
Totale 26.956
Salva come PNG Salva come JPEG
Città #
Chandler 1.542
Singapore 1.010
Ashburn 859
Dublin 604
Jacksonville 407
Jakarta 387
San Mateo 369
Milan 336
Dearborn 304
Wilmington 304
Woodbridge 274
Ann Arbor 267
Nanjing 255
Rome 223
Houston 221
Beijing 215
Boston 204
Redwood City 199
Moscow 196
Princeton 189
Hyderabad 187
Los Angeles 186
Cattolica 174
Seattle 171
Fairfield 161
New York 156
Lancaster 135
Hefei 134
Nürnberg 130
Munich 129
Lawrence 118
Chicago 117
Redmond 114
Marseille 112
Oviedo 112
Nanchang 110
Seoul 109
Frankfurt am Main 105
São Paulo 90
Hangzhou 88
Bremen 84
Helsinki 82
Toronto 74
Boardman 73
Izmir 71
The Dalles 63
Warsaw 63
Florence 60
Hong Kong 60
Norwalk 60
Abidjan 59
Brussels 59
Mountain View 58
London 51
Kunming 48
Cambridge 47
Hebei 47
Nuremberg 44
Shenyang 43
Tianjin 40
Washington 40
Zawidów 40
Düsseldorf 39
Pune 39
Zhengzhou 39
San Francisco 38
Shanghai 37
Guangzhou 34
Brooklyn 33
Busto Arsizio 33
Changsha 32
Naples 32
Auburn Hills 31
Jiaxing 31
Santa Clara 31
Sydney 31
Vienna 31
Bologna 30
Brno 30
Lappeenranta 30
Melbourne 30
Belo Horizonte 29
Phoenix 29
Tokyo 29
Buffalo 28
Leawood 28
Portland 26
Amsterdam 25
Brisbane 25
Philadelphia 25
Augusta 24
Lauterbourg 24
Asan 23
Buenos Aires 23
University Park 23
Adelaide 22
Portsmouth 22
Curitiba 21
Hanoi 21
Rio de Janeiro 21
Totale 13.368
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.623
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 373
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 323
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 291
Dasatinib first-line: Multicentric Italian experience outside clinical trials 267
Dasatinib first-line: Multicentric Italian experience outside clinical trials 267
comparison of haploidentical bone marrow versus matchet unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute leukemia 250
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 245
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 188
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 179
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 165
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 163
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 158
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 157
Correlation between paraproteinaemia and viral reactivation after allo-SCT 154
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 150
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 149
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 147
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 146
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 145
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 142
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 139
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 139
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 139
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 138
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 137
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 137
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 135
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 132
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 131
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 129
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 129
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 129
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 127
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 126
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 126
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 118
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 118
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 118
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 117
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 115
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 115
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 115
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 114
Work related acute leukemia and mucor mycosis in a boat-builder 113
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 112
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 111
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 110
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 110
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 109
Neurologic improvement after peripheral blood stem cell transplantation in poems 109
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 109
Hyperleukocytosis and leukostasis: management of a medical emergency 109
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 108
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 108
Hyperleukocytosis and leukostasis: management of a medical emergency 108
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 107
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 107
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 106
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 103
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 103
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 103
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 102
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 100
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 99
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 99
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 98
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 97
Clonal evolution in therapy-related neoplasms 97
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 97
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 95
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 95
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 95
Eltrombopag for the treatment of poor graft function following allogenic stem cell transplant: a retrospective multicenter study 94
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 93
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 93
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 92
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 91
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 89
Blinatumomab as a successful and safe therapyin Down syndrome patients with relapsed / refractory b-precursor acute lymphoblastic leukemia: Case report and literature review 89
SARS-COV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria an italian multicenter survey 88
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 85
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes 85
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 84
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 84
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 84
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 83
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement 83
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 83
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 82
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 81
Changes in protein serum levels during stem cell transplantation 80
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 80
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 79
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 79
The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma 78
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 78
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 78
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 78
Totale 14.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 0 0 0 0 0 0 0 176
2020/20212.210 435 239 76 125 184 109 139 62 291 90 386 74
2021/20222.628 249 128 75 139 162 78 66 390 140 179 507 515
2022/20235.174 754 661 414 708 373 621 263 337 571 183 196 93
2023/20244.039 124 853 194 210 218 561 243 157 165 271 499 544
2024/20257.163 429 341 649 566 591 289 323 348 1.116 793 1.591 127
Totale 27.550